The effect of the cannabinoid receptor antagonist AM251 on WIN 55,... | Download Scientific Diagram
4 Dose-dependent induction of cannabinoid tetrad effects by the SCB WIN... | Download Scientific Diagram
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain | Molecular Psychiatry
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells | Prostate Cancer and Prostatic Diseases
Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission | Scientific Reports
WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research
The cannabinoid agonist WIN 55,212-2 (WIN) reversibly inhibits... | Download Scientific Diagram
Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience
Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity - Mouro - 2018 - Journal of Neurochemistry - Wiley Online Library
WIN 55,212-2 mesylate | ≥99%(HPLC) | CB receptor agonist | AdooQ®
Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain | Journal of Pharmacology and Experimental Therapeutics
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research
Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells - ScienceDirect
What is a cannabinoid? — Why Not THC
WIN 55,212-2 - Wikipedia
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology & Translational Science
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
The cannabinoid receptor agonist WIN 55,212-2 (WIN) (( R)... | Download Scientific Diagram
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience
Effects of Acute Cannabinoid Agonist WIN 55, 212-2 Administration on Repeated Downshifts in Autshaping with Rats
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
Effect of the synthetic cannabinoid agonist WIN 55212-2 (WIN) on... | Download Scientific Diagram
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
